AudiologyOnline Phone: 800-753-2160


Oticon Medical Ponto 5 Family - April 2022

Amplifi Hearing Announces New EarScript.net Web-enabled Version

Share:

Annandale, NJ – April 15, 2024 Amplifi Hearing, a company focused on advancing hearing care delivery today announced the release of EarScript.net, our web-enabled version of our
EarScript hearing aid comparison app and system. EarScript is a patented* process that enables a patient to listen to a variety of hearing aids in different listening conditions that are programmed for their own hearing loss, offering a better way to compare and select the best hearing device to meet their needs. The app increases patient engagement and overall satisfaction during the hearing care journey.

When implemented on a hearing care provider website or app, EarScript.net provides several key benefits:

  • Pre-visit consumer engagement helps to promote office/store visits
  • Objective In-store/office hearing aid selection and likelihood of reduced trials resulting a quicker time to sale, and
  • Higher customer satisfaction due to a more engaging and realistic experience pre-sale

The EarScript.net software system consists of two key elements:

Amplifi

EarScript.net is offered on an annual subscription basis and is now available for licensing to hearing care organizations who wish to add significant patient engagement and efficiency to their practice or company websites.

For more information about this exciting new product, please contact Amplifi Hearing at +1 610.590.1590 or visit the product webpage at www.amplifihearing.com.

* U.S. Patent 9,154,888 Canadian Patent 2,876,251

About Amplifi Hearing

Amplifi Hearing was formed in 2021 by hearing care industry veterans to develop and offer tools that help improve the way hearing healthcare is delivered. The company’s founders have many decades of combined experience in the hearing care industry.

Sennheiser Hearing - June 2024

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.